Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noscamson Feb 11, 2021 2:52pm
278 Views
Post# 32543090

RE:RE:RE:RE:RE:Investment friend checked into ONCY

RE:RE:RE:RE:RE:Investment friend checked into ONCY
HCallahann44 wrote: "Double the number of survivals" ??? this is dishonest...the reason we are stuck in this range per my biotech analyst friend is that the studies have been small....and the results have small incremental improvements treatment rather than any slam dunk cures...Why would a Pharma throw billions at us when there are dozens of small biotechs working on the same solutions...they can just sit back...let us burn our cash proving the concept then swing down and take us out with little risk....I have a smaller position in XCUR but honestly that looks like a better play...better capitalized..they are going after cancer...but also hair loss and autoimmune diseases....Gates...and the principles of Groupon and Uber have provided the seed money...I am out of my league on this stuff so defer to the recommendations of by my analyst friend and some of the more knowledgeable posters here....I have a sizeable position because this seems like a decent lottery ticket...and I want generational wealth...but might be smarter to follow the herd in the bitcoins....


I think they are just a bunch of Chislers looking for cheap shares...
<< Previous
Bullboard Posts
Next >>